Objective The aim of our study was to analyse the perceptions of the public on medicine information and safety and on consumer reporting of suspected adverse drug reactions (ADR). Methods A voluntary survey was conducted in a population ≥18 years of age in Asturias, a region in northern Spain. The survey was designed to be completed in a face-to-face street interview or completed independently by the public. The survey consisted of structured questions organised in four sections: (1) demographic data, (2) use of medicines, (3) reading and understanding of the patient information leaflet (PIL) and (4) awareness and perception about consumer reporting of ADR. Key findings A total of 402 surveys were given and analysed; 295 were completed independently and 107 were completed in street interviews. Of the population surveyed, 82.3% had taken some drug(s) in the previous 3 months, although only 62.4% had performed so by medical prescription. A quarter of respondents claimed that they never read the PIL of medicines, 12.7% that they sometimes read it, and 61.4% that they always read this information. A high percentage (82.8%) of respondents reported that they were not aware of consumer reporting of ADR, and 86.1% stated their agreement with this option. Conclusions The public has great interest in useful information about all aspects involved in the use of medicines. This includes consumer reporting of suspected ADR, which is still unknown to many people.
Introduction
Medical practice has always been guided by ethical principles. The principle of autonomy takes into account the rights of individuals to actively participate in the decisions involved in their own health and, by extension, the right to access sufficient information to be able to carry out this activity. [1] In recent decades, demographic, economic, technological and educational changes in the population have resulted in a new model of patient who is better informed and is an active player in self-care and shared decision-making. [2] The concept of a 'patient-centred approach' is directly related to the concept of 'patient empowerment', which refers to patients shedding their passive role and playing an active part in decision-making processes that impact their health and quality of life. [3, 4] The aim of spontaneous reporting systems is to detect new signals, and to do that, pharmacovigilance centres need many good-quality reports. [5] There is evidence to show that new and novel adverse reactions can be detected through consumer reporting. [6] European legislation that came into effect in July 2012 [7] urges member states to develop tools to facilitate the direct spontaneous reporting of suspected adverse drug reactions (ADR) by patients. Until then, in Spain, spontaneous ADR reporting was based on reports of health professionals to the health authorities. [8, 9] In compliance with the abovementioned European legislation, in 2013, the Spanish Ministry of Health, Social Services and Equality published a new directive, [10] and the Spanish Agency of Medicines and Medical Devices developed an electronic format to collect reports of suspected ADR directly from consumers, through a direct link from its website. This option was published in a safety warning in January 2013. [11] Consumer reporting of ADR gives new perspectives on the public's own unfiltered experiences of the side effects of drugs in a way that is not otherwise available. [12] [13] [14] [15] The growing numbers of patient reports indicate European patients' high motivation to report ADR and suggest that the new European Union pharmacovigilance legislation has made a positive impact by empowering patients. [16] However, since the option of patient reporting was introduced in Spain, it has not been publicly promoted. Furthermore, there are no publicly available reports of ADRs reported directly by patients. Therefore, the aim of our study was to analyse the public's perceptions on medicine information and safety and on direct patient reporting of suspected ADR.
Methods
The study was carried out by researchers of the University of Oviedo in the Principality of Asturias, Spain, as part of a research project aimed to foster spontaneous reporting of ADR by consumers. This project (65/2012) was approved by the Clinical Research Ethics Committee. The Principality of Asturias is a region located in northern Spain, with an area of 10 603.57 km 2 and a total population of 1 034 449 inhabitants.
A voluntary survey of people ≥18 years of age in the Principality of Asturias in the cities of Oviedo, Gij on and Avil es and the towns of Langreo and Cangas del Narcea was conducted between May 2014 and May 2015. Based on the study published by Krska et al., [17] a survey written in Spanish was developed. At the top of the first page of the questionnaire, a box explaining the subject and aim of the survey was included. All members of the research team contributed to the development of the questions. At the beginning of the study, two researchers worked together to deliver the first 50 surveys. After this pilot period, the survey was reviewed by the research team, and some minor corrections were made to the content and order of questions.
The questionnaire was designed to be completed in a face-to-face street interview or independently by the public. In the street interviews, the people surveyed were randomly selected by the researcher. At the beginning of the interview, the survey was presented as part of a research project at the university, and the subject and the aim of the study were explained. Self-completed surveys were mainly completed in six social centres in Oviedo in collaboration with the person in charge. In Spain, there is a network of social centres aimed at the whole population that provide activities related to social information delivery, entertainment and community sociocultural promotion. In each of these centres, around 50 survey forms were left, and 1-2 weeks later, a researcher collected the completed surveys.
The survey consisted of structured questions organised in four sections: (i) demographic data: age, sex and level of education, including a question on health education: four closed questions; (2) use of medicines: six closed questions; (3) 
Results

Demographic data
Of the population asked to participate, only 23 people declined to participate in the study. A total of 487 surveys were returned, but 17.5% (85/487) were excluded from the analysis: 15.8% (77/487) because respondents had some type of health education and 1.7% (8/487) due to incomplete information or methodological reasons (age < 18 years). Of the remaining 402 analysed surveys, 73.4% (295/402) were completed by the respondents and 26.6% (107/402) were completed by the researcher, according to the information provided by the respondent. Table 1 shows the demographic details of the surveyed population compared with the overall Spanish population according to the 2011 census data. [19] Use of medicines
The results obtained in this section are summarised in 
Reading and understanding the patient information leaflet
A quarter [24.9% (100/402)] of respondents claimed that they never read the PIL, whereas 12.7% (51/402) sometimes read it and 61.4% (247/402) always read this information (Table 3) . Of those who always read the PIL ( The level of understanding of the PIL seemed to be related to age and level of education (Table 3) . Among the respondents aged between 18 and 45 years, only 6.1% (10/ 165) claimed to have difficulties understanding PIL, versus 25.4% (17/67) in the group aged 65 years or older. Furthermore, only 7% (9/129) of the respondents with higher education, versus 15.8% (3/19) of respondents with no education, reported difficulties in understanding the PIL.
Perception of drug safety
To the question: 'In your opinion, what type of medicine is safer?' (Table 5) , 69.4% (279/402) responded that prescribed medicines are safer than non-prescribed, and 17.4% (70/402) replied that both prescribed and non-prescribed medicines are equally safe. The perception of drug safety seems to differ depending on the age group. In the opinion of 60.6% (100/165) of the respondents aged between 18 and 45 years versus 89.6% (60/67) of the respondents aged 65 years or older (P < 0.01), prescribed medicines are safer than non-prescribed. On the other hand, 73.1% (294/402) reported not knowing who regulates medicines in Spain.
In relation to the use of the Internet in general, 41.3% (166/402) of the respondents reported that they always used it, 34.8% (140/402) reported using it sometimes, and 20.6% (83/402) reported that they never used it. The level of Internet use was clearly dependent on the age group analysed (P < 0.01), being higher in younger interviewees, and increasing proportionally with the level of education (P < 0.01). It is important to highlight that in the group aged 65 years or more, 67.2% (45/67) of the respondents reported that they never used the Internet.
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Discussion
This study presents some aspects of the public's viewpoints on medicine consumption, the use of PIL as a source of information about medications and the awareness level of the population concerning consumer reporting of suspected ADR. In our observations, people in general show great interest in any information about medicines, and therefore, collecting and ascertaining their observations in relation to ADR or other medicationrelated problems could be an interesting area for future research. The study covers the views of the public of different ages and levels of education but it is not specifically focus on the views of patients or people affected by severe diseases. The limitations of the study include potential bias in the collection of the responses in the street interviews or lack of information in the self-completed surveys. Furthermore, the combined analysis of 'do not know' plus 'no reply' options was an additional limitation in the analysis of some questions.
In our results, the declared medicine consumption in the previous three months was higher than that found by Krska et al. [17] in a similar survey performed in the U.K., although according to the 2014 Eurostat Report on Medicine Use Statistics, [20] the percentages of use of non-prescribed medicines were lower in the Spanish versus British (21.9% versus 43.3%) population and of prescribed medicines were similar (53.1% versus 53.0%). On the other hand, nearly 20% of respondents reported that they had been consuming some type of medicine without a prescription, and this figure was greater in the younger group and in the group with a higher level of education. These observations are in agreement with other studies performed in Spain; Jimenez-Rubio et al., [21] in a study on self-medication in the previous 2 weeks, found that 14% of individuals (100) 67 (100) 6 (100) 257 (100) 145 (100) 129 (100) 94 (100) 151 (100) 19 (100) 9 (100) 402 (100) 2. Do you find the PIL difficult to understand? (100) 129 (100) 94 (100) 151 (100) 19 (100) 9 (100) 402 (100) DK, do not know; NR, no reply; NA, not appropriate; Unk, unknown. (100) 129 (100) 94 (100) 151 (100) 19 (100) (100) 129 (100) 94 (100) 151 (100) 19 (100) (100) 129 (100) 94 (100) 151 (100) 19 (100) 9 (100) 402 (100) 4. Do you know that consumers can directly report suspected ADR? (100) 129 (100) 94 (100) 151 (100) 19 (100) (100) 129 (100) 94 (100) 151 (100) 19 (100) 9 (100) 402 (100) 6. In your opinion, should consumers receive more information about this option? consumed some medicines without a medical prescription, and this was also more common in the younger population. In contrast, we observed that only a small proportion of consumption of medicines without a prescription was based on pharmacist advice, with self-medication being the more common scenario. It is important to underline that according to the Centro de Investigaciones Sociol ogicas [22] in Spain, 15.1% of the population admits to keeping spare packs of medicines at home. The use of these stored medicines plus the purchase of some medicines without a medical prescription could be the basis of the self-medication detected in our study. A large part of the population surveyed in our study knew the reason why they were taking some drug(s), and this knowledge was more common in the older people surveyed. In our opinion, this high level of knowledge could be related to the higher use of prescribed medicines that is common in this age group. [23] However, more widespread knowledge of other points related to the management of pharmacological treatments, such as the duration of these treatments, seems to require an improvement in the information provided to patients by health professionals.
With regard to the PIL as a drug information source, the majority of the population claimed to always or sometimes read the PIL, which is in agreement with previous reports from Spain [24] and other countries. [25, 26] The level of comprehension of the PIL in our observations was high, although older people and people with a lower level of education present more difficulties in the comprehension of the PIL. To improve the understanding of the PIL and to promote their use, several measures, such as the inclusion of short, structured and visual/text explanations, have been proposed. [27] [28] [29] Competent authorities for the regulation of medicines in several European countries have recently reviewed their practices regarding communication about the safety of medicines. [30] Some previous studies [27, 31, 32] have indicated that information on drug safety is the most-read part of the PIL. However, in our study, only the population that occasionally read the PIL reported this preference. Globally considered, the population we surveyed did not show a preference for reading the information on drug safety in the PIL compared to the indications and dose or duration of treatments, underlining the interest of the public in all aspects of drug use.
In general terms, we observed a low awareness of drug safety, who regulates medicines in Spain and the new option for consumers to directly report ADR. The awareness of these issues found in our study was slightly lower than that found in Portugal [33] but similar to that observed in the UK. [17] Moreover, the majority of our surveyed population showed a positive attitude after being informed of consumer reporting of ADR, in agreement with previous observations.
[ [34] [35] [36] [37] To facilitate consumer reporting of ADR, drug regulatory agencies and pharmacovigilance centres have developed websites for online reporting. [38, 39] In this sense, it is important to emphasise that, according to a recent national survey conducted in Spain, [22] 18.1% of the Spanish population regards it as 'not necessary' to have Internet access at home, a similar percentage to that found in our survey. This suggests the importance of developing complementary systems of reporting, such as telephone lines or paper formats that can facilitate the collaboration of this population group.
Conclusion
The public has great interest in useful information about all aspects of the use of medicines: efficacy, safety, indications and duration of treatments. In relation to drug safety, consumer reporting of suspected ADR is not sufficiently well known but is greatly appreciated, especially by people with a high level of education and young people.
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